Data is the lifeblood of the life sciences. As therapeutics, medical devices, and diagnostics advance from early-stage development into clinical [...]
The life sciences industry has rapidly changed over the past twenty years. Drug development, historically, used to rely on vertically-integrated [...]
Developing new drugs is an expensive, time-consuming endeavor. A critical output of the drug development process, besides the compound itself, is data. As you may have read recently, Zolgensma™ re-surfaced [...]
Data drives the life sciences. Data supports the development of new products and enables agile decision making. But for a field so completely reliant on data, the industry is struggling to find methods [...]
Those who have worked in the life sciences industry have undoubtedly observed a sea of change in the discipline over the past twenty years. From new modalities (like CAR-T to microbiome) to external collaborations, [...]
The life sciences industry is responsible for the discovery, development, and commercialization of new medicines to treat disease. Over the past 20 years, the discipline has undergone massive changes. [...]